94 related articles for article (PubMed ID: 15309730)
1. ADAM17 mRNA expression and pathological features of hepatocellular carcinoma.
Ding X; Yang LY; Huang GW; Wang W; Lu WQ
World J Gastroenterol; 2004 Sep; 10(18):2735-9. PubMed ID: 15309730
[TBL] [Abstract][Full Text] [Related]
2. Association Patterns of Ontological Features Signify Electronic Health Records in Liver Cancer.
Chan LWC; Wong SCC; Chiau CC; Chan TM; Tao L; Feng J; Chiu KWH
J Healthc Eng; 2017; 2017():6493016. PubMed ID: 29065631
[TBL] [Abstract][Full Text] [Related]
3. Lost expression of ADAMTS5 protein associates with progression and poor prognosis of hepatocellular carcinoma.
Li C; Xiong Y; Yang X; Wang L; Zhang S; Dai N; Li M; Ren T; Yang Y; Zhou SF; Gan L; Wang D
Drug Des Devel Ther; 2015; 9():1773-83. PubMed ID: 25848214
[TBL] [Abstract][Full Text] [Related]
4. Sorafenib inhibits the shedding of major histocompatibility complex class I-related chain A on hepatocellular carcinoma cells by down-regulating a disintegrin and metalloproteinase 9.
Kohga K; Takehara T; Tatsumi T; Ishida H; Miyagi T; Hosui A; Hayashi N
Hepatology; 2010 Apr; 51(4):1264-73. PubMed ID: 20099300
[TBL] [Abstract][Full Text] [Related]
5. Role of Some microRNA/ADAM Proteins Axes in Gastrointestinal Cancers as a Novel Biomarkers and Potential Therapeutic Targets-A Review.
Kalita A; Sikora-Skrabaka M; Nowakowska-Zajdel E
Curr Issues Mol Biol; 2023 Apr; 45(4):2917-2936. PubMed ID: 37185715
[TBL] [Abstract][Full Text] [Related]
6. Molecular Targets and Signaling Pathways of microRNA-122 in Hepatocellular Carcinoma.
Chun KH
Pharmaceutics; 2022 Jun; 14(7):. PubMed ID: 35890276
[TBL] [Abstract][Full Text] [Related]
7. NGF/TRKA Promotes ADAM17-Dependent Cleavage of P75 in Ovarian Cells: Elucidating a Pro-Tumoral Mechanism.
Garrido MP; Vallejos C; Girardi S; Gabler F; Selman A; López F; Vega M; Romero C
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216240
[TBL] [Abstract][Full Text] [Related]
8. ADAM and ADAMTS Proteins, New Players in the Regulation of Hepatocellular Carcinoma Microenvironment.
Théret N; Bouezzedine F; Azar F; Diab-Assaf M; Legagneux V
Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33805340
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of hepatocellular carcinoma cell proliferation, migration, and invasion by a disintegrin and metalloproteinase-17 inhibitor TNF484.
Xia C; Zhang D; Li Y; Chen J; Zhou H; Nie L; Sun Y; Guo S; Cao J; Zhou F; Li J
J Res Med Sci; 2019; 24():26. PubMed ID: 31007696
[TBL] [Abstract][Full Text] [Related]
10. Rapid and sensitive detection of the activity of ADAM17 using a graphene oxide-based fluorescence sensor.
Zhang Y; Chen X; Roozbahani GM; Guan X
Analyst; 2019 Feb; 144(5):1825-1830. PubMed ID: 30675599
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of a disintegrin and metalloproteinase 21 is associated with motility, metastasis, and poor prognosis in hepatocellular carcinoma.
Honda H; Takamura M; Yamagiwa S; Genda T; Horigome R; Kimura N; Setsu T; Tominaga K; Kamimura H; Matsuda Y; Wakai T; Aoyagi Y; Terai S
Sci Rep; 2017 Nov; 7(1):15485. PubMed ID: 29138461
[TBL] [Abstract][Full Text] [Related]
12. The B7 Family Member B7-H6: a New Bane of Tumor.
Chen Y; Mo J; Jia X; He Y
Pathol Oncol Res; 2018 Oct; 24(4):717-721. PubMed ID: 29086181
[TBL] [Abstract][Full Text] [Related]
13. Hepatocyte specific TIMP3 expression prevents diet dependent fatty liver disease and hepatocellular carcinoma.
Casagrande V; Mauriello A; Bischetti S; Mavilio M; Federici M; Menghini R
Sci Rep; 2017 Jul; 7(1):6747. PubMed ID: 28751722
[TBL] [Abstract][Full Text] [Related]
14. Role of ADAM17 in invasion and migration of CD133-expressing liver cancer stem cells after irradiation.
Hong SW; Hur W; Choi JE; Kim JH; Hwang D; Yoon SK
Oncotarget; 2016 Apr; 7(17):23482-97. PubMed ID: 26993601
[TBL] [Abstract][Full Text] [Related]
15. Loss of hepatocyte ERBB3 but not EGFR impairs hepatocarcinogenesis.
Scheving LA; Zhang X; Stevenson MC; Weintraub MA; Abbasi A; Clarke AM; Threadgill DW; Russell WE
Am J Physiol Gastrointest Liver Physiol; 2015 Dec; 309(12):G942-54. PubMed ID: 26492920
[TBL] [Abstract][Full Text] [Related]
16. ADAM-12 as a diagnostic marker for the proliferation, migration and invasion in patients with small cell lung cancer.
Shao S; Li Z; Gao W; Yu G; Liu D; Pan F
PLoS One; 2014; 9(1):e85936. PubMed ID: 24465799
[TBL] [Abstract][Full Text] [Related]
17. Epidermal Growth Factor Receptor (EGFR) Crosstalks in Liver Cancer.
Berasain C; Ujue Latasa M; Urtasun R; Goñi S; Elizalde M; Garcia-Irigoyen O; Azcona M; Prieto J; Avila MA
Cancers (Basel); 2011 May; 3(2):2444-61. PubMed ID: 24212818
[TBL] [Abstract][Full Text] [Related]
18. Effects of tetrandrine on glioma cell malignant phenotype via inhibition of ADAM17.
Wu Z; Wang G; Xu S; Li Y; Tian Y; Niu H; Yuan F; Zhou F; Hao Z; Zheng Y; Li Q; Wang J
Tumour Biol; 2014 Mar; 35(3):2205-10. PubMed ID: 24185966
[TBL] [Abstract][Full Text] [Related]
19. Novel RNA oligonucleotide improves liver function and inhibits liver carcinogenesis in vivo.
Reebye V; Sætrom P; Mintz PJ; Huang KW; Swiderski P; Peng L; Liu C; Liu X; Lindkaer-Jensen S; Zacharoulis D; Kostomitsopoulos N; Kasahara N; Nicholls JP; Jiao LR; Pai M; Spalding DR; Mizandari M; Chikovani T; Emara MM; Haoudi A; Tomalia DA; Rossi JJ; Habib NA
Hepatology; 2014 Jan; 59(1):216-27. PubMed ID: 23929703
[TBL] [Abstract][Full Text] [Related]
20. ADAM17 mediates hypoxia-induced drug resistance in hepatocellular carcinoma cells through activation of EGFR/PI3K/Akt pathway.
Wang XJ; Feng CW; Li M
Mol Cell Biochem; 2013 Aug; 380(1-2):57-66. PubMed ID: 23625205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
